The First Affiliated Hospital of Henan University of Science and Technology
Welcome,         Profile    Billing    Logout  
 250 Trials 
1125 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Huang, Yan
HS-10234-401, NCT06743438: Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB

Active, not recruiting
4
640
RoW
Tenofovir Amibufenamide(TMF), HS-10234
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Hepatitis B, Chronic
06/24
09/29
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

Recruiting
3
1041
RoW
YZJ-1139 20mg, YZJ-1139 40mg, Placebo
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Insomnia Disorder
12/24
12/24
NCT05115942: Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.

Completed
3
248
RoW
Hydronidone capsules, F351, The placebo capsules, N
Beijing Continent Pharmaceutical Co, Ltd.
Liver Fibrosis
10/24
10/24
NCT06521255: Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Recruiting
3
244
RoW
Tafasitamab, Lenalidomide, Gemcitabine, Oxaliplatin, Rituximab
Beijing InnoCare Pharma Tech Co., Ltd.
DLBCL
09/28
12/29
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
NCT05905172: Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

Recruiting
3
248
RoW
Hydronidone capsules, F351, The placebo capsules, N
Beijing Continent Pharmaceutical Co, Ltd.
Liver Fibrosis
06/28
10/28
SURPASS, NCT05623267: Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Recruiting
2/3
346
RoW
Sugemalimab, Placebo
Sun Yat-sen University
Limited Stage Small Cell Lung Cancer
12/25
03/27
TRIDENT, NCT05245994: An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Recruiting
2
60
RoW
Durvalumab, etoposide, and cisplatin/carboplatin followed by durvalumab and olaparib
Li Zhang, MD
Lung Cancer, Small Cell Lung Cancer, Durvalumab
05/23
11/23
NCT06601504: Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

Recruiting
2
60
RoW
HMPL-760 planned dose 1, R-GemOx, Rituximab Injection, Gemcitabine Hydrochloride for Injection, Gemcitabine Hydrochloride for Injection, HMPL-760 placebo planned dose 1, HMPL-760 planned dose 2, HMPL-760 placebo planned dose 2
Hutchmed
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
05/26
11/26
NCT04211805: Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B

Recruiting
N/A
450
RoW
Tenofovir Alafenamide 25 MG for arm (A), HBIg 200 IU im for infants, HBV vaccine 10 ug im for infants, Tenofovir Disoproxil Fumarate 300mg for arm (B)
New Discovery LLC
Hepatitis B, Chronic, Pregnancy Related
09/21
09/21
NCT03161002: Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor

Recruiting
N/A
400
RoW
detection of genotype
Cui Yimin
Ticagrelor, Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Accurate Medication
10/21
12/21
NCT05190861: Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis

Recruiting
N/A
2000
RoW
droplet digital PCR method, blood culture
Huashan Hospital
Sepsis, Septic Shock
12/22
06/23
NCT03108794: A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B

Recruiting
N/A
200000
RoW
Beijing Friendship Hospital, Beijing YouAn Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Beijing Ditan Hospital, First Affiliated Hospital of Xinjiang Medical University, LanZhou University, The Second Affiliated Hospital of Chongqing Medical University, West China Hospital, Taiyuan No.3 Hospital, Hebei Medical University Third Hospital, Shengjing Hospital, Tianjin Third Central Hospital, Peking University First Hospital, Peking Union Medical College Hospital, The Affiliated Hospital Of Southwest Medical University, Shanghai Public Health Clinical Center, Ruijin Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xiangya Hospital of Central South University, Beijing Tiantan Hospital, Wuhan University, The First Affiliated Hospital of Kunming Medical College, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Hospital of Yanbian University, First Affiliated Hospital of Chongqing Medical University, The Fouth Hospital of Qinghai province, Weifang Medical University, Hunan Provincial People's Hospital, The Second Hospital of Hebei Medical University, Xixi Hospital of Hangzhou, General Hospital of Ningxia Medical University, Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Peking University People's Hospital, Nanfang Hospital of Southern Medical University, The Affiliated Hospital Of Guizhou Medical University, Guizhou Provincial People's Hospital, Hainan General Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Fifth Hospital of Shijiazhuang City, Yan'an University Affiliated Hospital, Infectious Disease Hospital of Wuhai, Logistics University of Chinese People's Armed Police Forces, People's Hospital of Changji Hui Autonomous Prefecture,Xinjiang
Chronic Hepatitis B
12/22
12/25
TRUE, NCT03752658: TAF Real World Study for Universal Effectiveness

Recruiting
N/A
500
RoW
Tenofovir Alafenamide, Vemlidy®
Tongji Hospital, Gilead Sciences
Chronic Hepatitis b
05/23
09/23
NCT04564651: Platelet Transfusion in Acute-on Chronic Liver Failure

Recruiting
N/A
80
RoW
platelet transfusion
Nanfang Hospital of Southern Medical University
Acute-On-Chronic Liver Failure
05/24
05/24
NCT05393453: Prognosis of Patients With Acute-on-chronic Liver Failure

Recruiting
N/A
500
RoW
Xiangya Hospital of Central South University
Acute-On-Chronic Liver Failure
06/24
06/25
NCT05422651: Observational Study About In-patients Admitted With Fever

Recruiting
N/A
500
RoW
Xiangya Hospital of Central South University
Fever
08/24
08/26
NCT05140837: Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

Recruiting
N/A
10000
RoW
Psychometric hepatic encephalopathy score & Stroop test, Drug therapy
Hepatopancreatobiliary Surgery Institute of Gansu Province, The First Affiliated Hospital of Anhui Medical University, Beijing Ditan Hospital, Chongqing Public Health Medical Treatment Center, Meng Chao Hepatobiliary Hospital of Fujian Medical University, Guangxi Zhuang Autonomous Region People's Hospital, Shenzhen Third People's Hospital, Guizhou people's Hospital, Wuhan Union Hospital, China, Xiangya Hospital of Central South University, The Second Affiliated Hospital of Hainan Medical University, The Third Affiliated Hospital of Hebei Medical University, The Second Affiliated Hospital of Harbin Medical University, Henan Provincial People's Hospital, Ganzhou Fifth People's Hospital, The First Hospital of Jilin University, Jiangsu People's Hospital, First Hospital of China Medical University, The Second Affiliated Hospital of Baotou Medical College, Ningxia Medical University General Hospital, The Fourth People's Hospital of Qinghai Province, Xi'an High-tech Hospital, The 10th People's Hospital affiliated to Tongji University, Qilu Hospital of Shandong University, The Third People's Hospital of Taiyuan, Xichang People's Hospital, Tianjin Third Central Hospital, The Third People's Hospital of Tibet Autonomous Region, Xinjiang Autonomous Region People's Hospital, Second People's Hospital of Yunnan Province, Hangzhou Xixi hospital, LanZhou University
Hepatic Encephalopathy, Cirrhosis
12/24
12/24
NCT05625750: Observational Study About Patients Diagnosed With NAFLD

Recruiting
N/A
500
RoW
Xiangya Hospital of Central South University
Nonalcoholic Fatty Liver Disease
04/25
04/27
NCT05937178: Real-world Study Optimizing Nucleotide-analogues

Recruiting
N/A
20000
RoW
ETV/TAF/TDF/TMF/IFN, ETV/TAF/TDF/TMF
Huashan Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, Beijing YouAn Hospital, Peking University People's Hospital, Peking University First Hospital, Xiamen Hospital of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, LanZhou University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Hainan General Hospital, Hebei Medical University Third Hospital, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The Second Affiliated Hospital of Harbin Medical University, Tongji Hospital, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, the Second Hospital of Nangjing, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Hospital of Xuzhou Medical University, The First Affiliated Hospital of Nanchang University, Shengjing Hospital, Qingdao Sixth People's Hospital, Shandong Provincial Hospital Affiliated to Shandong First Medical University, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, West China Hospital, Tianjin Second People's Hospital, First Affiliated Hospital of Xinjiang Medical University, The First People's Hospital of Yunnan, Shulan (Hangzhou) Hospital, Zhejiang University, Southwest Hospital, China, The Second Affiliated Hospital of Chongqing Medical University, Sichuan Provincial People's Hospital
Hepatitis B, Chronic
01/29
01/29
NCT05086536: Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis

Not yet recruiting
N/A
600
RoW
no intervention
Beijing Friendship Hospital, Beijing YouAn Hospital, Shandong Provincial Hospital, The Affiliated Hospital of Qingdao University, The First Affiliated Hospital of Shanxi Medical University, Xiangya Hospital of Central South University, The Second Affiliated Hospital of Baotou Medical College
Hepatitis B, Decompensated Cirrhosis
06/22
12/22
NCT05392387: Treatment and Prognosis of Patients With Chronic HBV Infection

Recruiting
N/A
500
RoW
Standard antiviral therapy
Xiangya Hospital of Central South University
Hepatitis B Virus Infection
10/24
10/26
Wang, Wei
ESPRESSO, NCT04641819: Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients

Active, not recruiting
4
1127
RoW
Yangzheng Compound Mixture, Z10970042(NMPA Approval Number), Conventional Treatment
ShuGuang Hospital, LinkDoc Technology (Beijing) Co. Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd
Carcinoma, Sleep Disorder
09/23
06/24
NCT05177926: Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)

Recruiting
4
330
RoW
antiviral prophylaxis with Tenofovir Alafenamide Fumarate
Nanfang Hospital of Southern Medical University, Gilead Sciences, Tigermed Consulting Co., Ltd
Hepatitis B, Chronic, Mother to Child Transmission
12/23
12/23
NCT05604859: Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)

Recruiting
4
350
RoW
Methylprednisolone, intravenous immunoglobulin, Tocilizumab, Low molecular weight heparin, conventional treatment
Qin Ning
Severe Fever With Thrombocytopenia Syndrome
12/23
06/24
TE-ITP, NCT05583838: A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Completed
4
157
RoW
rhTPO, Recombinant human thrombopoietin, TPIAO, Eltrombopag, Eltrombopag olamine
Institute of Hematology & Blood Diseases Hospital, China, The Second Hospital of Hebei Medical University, Xijing Hospital, The Affiliated Hospital of Inner Mongolia Medical University, The Second Affiliated Hospital of Kunming Medical University, Second Affiliated Hospital of Guangzhou Medical University, Shaanxi Provincial People's Hospital, Henan Cancer Hospital, North China University of Science and Technology Affiliated Hospital, The Second Affiliated Hospital of Dalian Medical University, Second Hospital of Shanxi Medical University, The Second Affiliated Hospital of Harbin Medical University, Shenyang Sunshine Pharmaceutical Co., LTD., First Affiliated Hospital of Xinjiang Medical University, People's Hospital of Xinjiang Uygur Autonomous Region, Kashgar 1st People's Hospital, Xi'an Central Hospital, Beijing Public Health Foundation, Yuyao People's Hospital of Zhejiang Province
Previously Treated Primary Immune Thrombocytopenia
02/24
07/24
NCT06009042: Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study

Recruiting
4
100
RoW
IVIG 20g/d, IVIG 10g/d
Tongji Hospital
HFRS (Hemorrhagic Fever With Renal Syndrome)
06/24
06/24
NCT06520397: Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease

Recruiting
4
214
RoW
Ustekinumab and Upadacitinib, Ustekinumab
Sixth Affiliated Hospital, Sun Yat-sen University
Crohn Disease
12/26
07/27
NCT06798324: TDCS Plus Varenicline for Smoking Cessation

Not yet recruiting
4
160
Canada
Active Transcranial Direct Current Stimulation (tDCS), Varenicline 1mg BID, Champix, Chantix, Sham Transcranial Direct Current Stimulation (tDCS)
Centre for Addiction and Mental Health, Canadian Institutes of Health Research (CIHR)
Nicotine Dependence, Tobacco Smoking, Smoking Cessation, Nicotine Use Disorder, Tobacco Use Disorder, Substance Use Disorders
01/28
08/28
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Recruiting
4
364
RoW
Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline
Shanghai Pulmonary Hospital, Shanghai, China
Bronchiectasis Adult, Pseudomonas Aeruginosa Infection
10/25
12/25
GiCAEC, NCT04648917: GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC)

Recruiting
3
80
RoW
Caffeic acid
The First Affiliated Hospital of Henan University of Science and Technology
Esophagus Cancer, Stage III
05/21
05/22
HATCHED, NCT03716518: Herbal Treatment to Improve Chemotherapy Delivery

Recruiting
3
400
RoW
Tonifying Spleen and Kidney Sequential Regimen, TSKSR, Placebo of 'Tonifying Spleen and Kidney Sequential Regimen, Placebo of TSKSR
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, Peking University Third Hospital, Beijing Chao Yang Hospital, Jiangsu Province Hospital of Traditional Chinese Medicine, Shanghai Zhongshan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Tianjin Union Medical Center, Henan Provincial People's Hospital, Zhengzhou Hospital of Traditional Chinese Medicine, Peking University Cancer Hospital & Institute, Chongqing University Cancer Hospital, Civil Aviation General Hospital
Colon Cancer
05/21
05/21
NCT05236621: A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Active, not recruiting
3
85
RoW
Pomalidomide, Dexamethasone
Qilu Pharmaceutical Co., Ltd.
Multiple Myeloma, Recurrent or Refractory
06/22
12/23
CRTCOESC, NCT02025036: Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer

Active, not recruiting
3
249
RoW
Capecitabine(Aibin), Aibin, Oxaliplatin(Aiheng), Aiheng, Radiotherapy, Radiation Therapy
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang Central Hospital, Military 150 Hospital, Anyang Cancer Hospital, Nanyang Central Hospital, Henan Oncology Hospital, The First Affiliated Hospital of Xinyang Medical College, Sanmenxia Central Hospital
Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma
09/22
04/25
NCT05188989: Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.

Completed
3
765
RoW
TPN171H 2.5mg group, Simmerafil, TPN171H 5mg group, TPN171H 10mg group, Placebo group
Vigonvita Life Sciences
Erectile Dysfunction
02/23
02/23
FGCL-3019-095, NCT04419558 / 2020-000697-22: Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Apr 2024 - Sep 2024: Topline data from ZEPHYRUS-2 trial for IPF
Terminated
3
372
Europe, US, RoW
Pamrevlumab, FG-3019, Placebo
FibroGen
Idiopathic Pulmonary Fibrosis
09/23
09/23
NCT04385550: A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma

Not yet recruiting
3
528
RoW
Anlotinib hydrochloride capsule, AK105 injection, Paclitaxel injection, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma
10/23
12/23
Neo-CRAG, NCT01815853: Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer

Recruiting
3
620
RoW
Neoadjuvant Chemoradiotherapy, Neoadjuvant Chemotherapy, R0 D2 Gastrectomy, Adjuvant Chemotherapy
Sun Yat-sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Anhui Medical University, Liaoning Cancer Hospital & Institute, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangxi Medical University Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Zhejiang Cancer Hospital, First Hospital of China Medical University, First People's Hospital of Hangzhou
Gastric Cancer
12/23
12/25
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Recruiting
3
522
RoW
D-1553 Tablet, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
10/26
12/27
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

Recruiting
3
688
RoW
Radical colectomy, HIPEC, Systemic chemotherapy
Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University
Colorectal Cancer
04/24
04/26
HERIZON-GEA-01, NCT05152147 / 2021-000296-36: A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Recruiting
3
918
Europe, Canada, Japan, RoW
Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil
Jazz Pharmaceuticals, BeiGene, Ltd.
Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma
05/25
05/26
BENCH, NCT04939142: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Active, not recruiting
3
150
RoW
SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone)
Antengene Corporation
Relapsed or Refractory Multiple Myeloma
07/24
10/24
NCT04937387: Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma

Completed
3
359
RoW
FF/VI, FF/UMEC/VI, ELLIPTA
GlaxoSmithKline
Asthma
08/24
08/24
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis

Recruiting
3
552
RoW
ICP-332 Tablets, ICP-332 Placebo Tablets
Beijing InnoCare Pharma Tech Co., Ltd.
Atopic Dermatitis
11/26
12/26
NCT06004856: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Recruiting
3
195
RoW
Orelabrutinib, Placebo
Beijing InnoCare Pharma Tech Co., Ltd.
Chronic Primary Immune Thrombocytopenia (ITP)
12/25
04/26
NCT05768503: Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

Recruiting
3
176
RoW
Experimental drug, CAP, Control Rx, FOLFIRI+BEV
Sun Yat-sen University
Metastatic Microsatellite-stable Colorectal Cancer
01/26
01/27
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Active, not recruiting
3
878
RoW
JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy
Shanghai Junshi Bioscience Co., Ltd.
Gastric or Esophagogastric Junction Adenocarcinoma
06/26
07/28
NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Recruiting
3
552
RoW
Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA)
TJ Biopharma Co., Ltd.
Myelodysplastic Syndromes(MDS)
03/27
03/27
NCT04459754: Fuzheng Yiliu-1010

Recruiting
2
189
RoW
Fuzheng Yiliu Formulation
Guangdong Provincial Hospital of Traditional Chinese Medicine
Colorectal Cancer Stage II and III
12/21
12/24
ANSWER, NCT05214222: Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma

Recruiting
2
100
RoW
Anlotinib/Penpulimab/Chemotherapy, Anlotinib, Penpulimab, Paclitaxel or Albumin Paclitaxel,Cisplatin, Penpulimab/Chemotherapy, Penpulimab, Paclitaxel or Albumin Paclitaxel,Cisplatin
Nanfang Hospital, Southern Medical University
Advanced Esophageal Squamous Cell Carcinoma
06/26
09/28
2022-PUMCH-A-194, NCT06176729: Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients

Recruiting
2
30
RoW
Polatuzumab Vedotin, Rituximab, Lenalidomide
Yan Zhang, MD, Peking University Third Hospital, Peking University First Hospital, Chinese PLA General Hospital
Diffuse Large B Cell Lymphoma
10/25
10/27
NICE, NCT04744649: Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial

Recruiting
2
110
RoW
XELOX or SOX, Control group, JS001+XELOX or SOX, Experimental group and Exploratory group
Nanfang Hospital of Southern Medical University, Shanghai Junshi Bioscience Co., Ltd.
Gastric Cancer, Stomach Neoplasm
12/23
12/24
NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Recruiting
2
460
RoW
TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Obstructive Pulmonary Disease (COPD)
01/24
05/24
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Recruiting
2
88
RoW
RC88, RC88 for Injection
RemeGen Co., Ltd.
Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer
06/26
12/26
NAUTICALCRC, NCT05004350: A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.

Active, not recruiting
2
103
RoW
Encorafenib, Braftovi®, PF-07263896, W0090, LGX818, ONO-7702, Cetuximab, Erbitux®, C225, FOLFIRI, Folinic acid + Fluorouracil + Irinotecan
Pierre Fabre Medicament, Merck KGaA, Darmstadt, Germany
BRAF V600E, Metastatic Colorectal Cancer
12/23
01/25
NCT03941574: A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy

Recruiting
2
108
RoW
HLX10
Shanghai Henlius Biotech
MSI-H Solid Malignant Tumor
05/24
06/26
HLX10HLX07-001, NCT04297995: Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

Active, not recruiting
2
131
RoW
HLX10, HLX07, HLX07 placebo, Cisplatin/Carboplatin, 5-FU
Shanghai Henlius Biotech
Head and Neck Squamous Cell Carcinoma
05/24
06/25
NCT06454968: Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.

Recruiting
2
45
RoW
Orelabrutinib, obinutuzumab, lenalidomide
Peking Union Medical College Hospital
Marginal Zone Lymphoma
06/26
06/28
NCT05810350: Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles

Recruiting
2
40
RoW
Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed
Three Gorges Hospital of Chongqing University
Non-small Cell Lung Cancer
12/24
12/24
NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Not yet recruiting
2
168
RoW
TQH2722 injection, TQH2722 Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Seasonal Allergic Rhinitis
06/25
08/25
CEIL, NCT05959356: Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer

Recruiting
2
198
RoW
Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab or c225, Envafolimab, Irinotecan, Oxaliplatin, Leucovorin, 5-FU, Cetuximab + mFOLFOX6/FOLFIRI
Sun Yat-sen University
Metastatic Colorectal Cancer
12/25
12/27
HATCH, NCT04691141: A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS)

Terminated
1/2
15
RoW
ATG-016
Shanghai Antengene Corporation Limited
Myelodysplastic Syndrome
09/23
09/23
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies

Recruiting
1/2
1300
Canada, US, RoW
SKB264
Klus Pharma Inc.
Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer
08/25
07/26
NCT06106841: TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Recruiting
1/2
39
RoW
400mg of TQB3909 tablets, 600mg of TQB3909 tablets
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Mantle Cell Lymphoma
12/24
12/24
NCT04324138: Efficacy and Safety of Jianpi Qinghua Granules in Patients With Nonerosive Reflux Disease

Recruiting
1
78
RoW
Jianpi Qinghua granules, experimental drugs, Jianpi Qinghua placebo granules, placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Liaoning University of Traditional Chinese Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Nonerosive Reflux Disease
12/21
12/21
NCT02915445: EpCAM CAR-T for Treatment of Advanced Solid Tumors

Active, not recruiting
1
30
RoW
EpCAM CAR-T cells
Sichuan University
Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M), Breast Cancer Recurrent, Gastric Cancer With Metastasis
07/25
07/25
CARTinNS, NCT04561557: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Recruiting
1
36
RoW
CT103A cells, Cyclophosphamide and fludarabine
Tongji Hospital, Nanjing IASO Biotechnology Co., Ltd.
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Idiopathic Inflammatory Myopathies, Multiple Sclerosis, Autoimmune Encephalitis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), POEMS Syndrome
02/27
05/27
NCT04893759: A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors

Recruiting
1
60
RoW
Pelcitoclax, APG-1252
Ascentage Pharma Group Inc.
Neuroendocrine Tumors
06/24
06/25
NCT06608355: The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease

Recruiting
1
6
RoW
Human Dopaminergic Progenitor Cells
iRegene Therapeutics Co., Ltd.
Early-onset Parkinson's Disease
04/26
03/27
NCT06548607: Clinical Study on Targeted CD19 CAR-T Therapy for Autoimmune Diseases

Recruiting
1
20
RoW
RD06-04 CART Cell Injection
Nanjing Bioheng Biotech Co., Ltd.
SLE (Systemic Lupus), Systemic Sclerosis, ANCA Associated Vasculitis, Idiopathic Inflammatory Myopathies, Sjogren's Syndrome, Autoimmune Diseases
07/26
07/27
NCT06612710: The Safety and Efficacy of NouvSoma001 in Ischemic Stroke

Not yet recruiting
1
69
RoW
extracellular vesicles derived from human induced neural stem cell for intravenous injection, NouvSoma001, a placebo of extracellular vesicles derived from human induced neural stem cell for intravenous injection, NouvSoma001placebo
Tongji Hospital, iRegene Therapeutics Co., Ltd.
Ischemic Stroke
11/25
11/27
NCT06620809: The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

Not yet recruiting
1
69
RoW
Extracellular vesicles derived from human-induced neural stem cells for intrathecal injection, NouvSoma001, A placebo of extracellular vesicles derived from human-induced neural stem cells for intrathecal injection
Tongji Hospital, iRegene Therapeutics Co., Ltd.
Neuromyelitis Optica Spectrum Disorders
11/25
11/27
NCT05473624: Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors

Recruiting
1
153
RoW
HRS-1167
Jiangsu HengRui Medicine Co., Ltd.
Advanced Solid Tumors
12/24
12/24
CELAEC, NCT02972372: Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Recruiting
N/A
196
RoW
CRT, concurrent chemoradiotherapy, surgery, esophagectomy
The First Affiliated Hospital of Henan University of Science and Technology, Jiangsu HengRui Medicine Co., Ltd., Anyang Tumor Hospital, 150th Hospital of PLA
Esophagus Cancer
12/24
12/25
NCT04861376: Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia

Completed
N/A
174
RoW
Pueraria lobata, Pueraria thomsoni, Placebo
Jiangxi University of Traditional Chinese Medicine
Dyslipidemias
01/22
01/22
NCT04886193: FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis

Recruiting
N/A
20
RoW
FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1)
Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanghai Junshi Bioscience Co., Ltd.
Chemotherapy, Gastric Cancer
05/22
05/23
NCT04360577: Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy

Completed
N/A
240
RoW
acupuncture
Guangzhou University of Traditional Chinese Medicine, First Affiliated Hospital, Sun Yat-Sen University, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Sixth Affiliated Hospital, Sun Yat-sen University, Southern Medical University, China, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Guangzhou Medical University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Fifth Affiliated Hospital, Sun Yat-Sen University, First People's Hospital of Foshan, Yuebei People's Hospital
Stomach Neoplasms
03/23
05/23
SAFE-APD, NCT03598387: Automated Peritoneal Dialysis Versus Intermittent Hemodialysis in Acute Kidney Injury

Recruiting
N/A
100
RoW
Automated peritoneal dialysis, Intermittent hemodialysis
Limeng Chen, First Hospital of China Medical University, First Affiliated Hospital Xi'an Jiaotong University, Beijing Anzhen Hospital, Xiangya Hospital of Central South University, Baxter Healthcare Corporation
Acute Kidney Injury
12/22
12/22
NCT03792932: Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer

Recruiting
N/A
306
RoW
Laparoscopic distal pancreatectomy, Open distal pancreatectomy
Fudan University
Pancreatic Cancer, Surgery, Laparoscopy
01/23
01/23
GIANT, NCT04765592: Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System ( Study)

Active, not recruiting
N/A
88
RoW
WeFlow-Arch Modeler Embedded Branch Stent Graft System
Hangzhou Endonom Medtech Co., Ltd.
Aortic Arch Aneurysm
02/25
02/29
NCT04853238: Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China

Completed
N/A
1507
RoW
Prospective observational cohort study
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
11/22
02/23
SELECT-1, NCT04397432: Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC:Retrospective Study

Active, not recruiting
N/A
878
RoW
Tian Xie, LinkDoc Technology (Beijing) Co. Ltd.
Carcinoma, Non-Small-Cell Lung
04/23
03/26
LOFTY, NCT06577792: Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC

Recruiting
N/A
620
RoW
Lobectomy-First, Lymphadenectomy-First
Sun Yat-sen University, Tianjin Medical University Cancer Institute and Hospital, RenJi Hospital, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital of Jinan University, The First Affiliated Hospital with Nanjing Medical University, Hebei Medical University Fourth Hospital, Shanghai Changzheng Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Suining Central Hospital, Ningbo Medical Center Lihuili Hospital, Shanxi Provincial Cancer Hospital, The Affiliated Hospital of Xuzhou Medical University, The General Hospital of Eastern Theater Command, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial People's Hospital, Fujian Medical University Union Hospital, First Affiliated Hospital of Kunming Medical University, Fujian Provincial Hospital, Tianjin Chest Hospital, Sichuan Cancer Hospital and Research Institute, Shenzhen People's Hospital, Tang-Du Hospital, Shandong Provincial Hospital, Gansu Provincial Hospital, Wuhan Union Hospital, China, Wuhan TongJi Hospital, The Affiliated Hospital of Qingdao University, West China Hospital, The First Affiliated Hospital of Nanchang University, Jiangsu Cancer Institute & Hospital, Dongguan People's Hospital, First People's Hospital of Foshan
Non Small Cell Lung Cancer
12/24
12/29
DELTA, NCT05608655: DKutting Balloon Versus Chocolate Balloon to Treat Femoral and Popliteal Artery Stenosis

Completed
N/A
188
RoW
DKutting LL balloon, Chocolate balloon
DK Medical Technology (Suzhou) Co., Ltd.
Femoral Artery Stenosis, Popliteal Artery Stenosis
01/24
02/24
NCT04688944: The Correlation Between Degeneration of Paraspinal Muscle and Outcome of Patients With Lumbar Spinal Stenosis

Recruiting
N/A
200
RoW
observation
Peking University Third Hospital
Lumbar Spinal Stenosis, Paraspinal Muscle
10/23
01/24
NCT05193162: Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases

Recruiting
N/A
800
RoW
No any intervention, have no any intervention
Ruijin Hospital
Pancreatic Cancer, Pancreatic Disease, Microbial Colonization
12/23
07/26
NCT06011902: A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia Syndrome

Recruiting
N/A
1500
RoW
Tongji Hospital
Severe Fever With Thrombocytopenia Syndrome
12/23
03/24
NCT06020326: A Retrospective Cohort Study of HFRS

Recruiting
N/A
500
RoW
Tongji Hospital
HFRS
12/23
12/23
NCT04423354: A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG

Recruiting
N/A
94
RoW
Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Type Ⅱ Adenocarcinoma of Esophagogastric Junction
Guangdong Provincial Hospital of Traditional Chinese Medicine
Esophagogastric Junction Adenocarcinoma, Siewert Type II Adenocarcinoma of Esophagogastric Junction
02/24
03/24
NCT06333470: Liwan Eye Study: the Fourth Follow-up

Not yet recruiting
N/A
600
NA
Primary angle closure diseases
Zhongshan Ophthalmic Center, Sun Yat-sen University
Primary Angle-Closure Glaucoma
09/24
09/24
NCT06467773: TSPO-PET/MRI in Surveillance of Neuroinflammation in the Central Nervous System

Not yet recruiting
N/A
100
RoW
Radiation: PET-MRI with [18F]-DPA-714
Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd.
Central Nervous System Diseases
06/29
12/29
NCT05992701: Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease

Recruiting
N/A
28
RoW
Directional deep brain stimualtion
Beijing Pins Medical Co., Ltd, Beijing Tiantan Hospital, Changhai Hospital, the Second Military Medical University, Shenzhen Second People's Hospital, Wuhan University, West China Hospital, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, First Affiliated Hospital of Kunming Medical University, Nanjing Medical University, Tianjin Medical University General Hospital
Parkinson's Disease
06/24
06/24
NCT06385379: Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)

Recruiting
N/A
90
RoW
WeFlow-Tribranch embedded aortic Triple-branch arch Stent Graft system
Hangzhou Endonom Medtech Co., Ltd.
Aortic Arch Aneurysm
12/25
12/30
NCT03809247: Microbial Diversity of Pancreatic Diseases

Recruiting
N/A
330
RoW
Ruijin Hospital
Pancreatic Cancer, Pancreatic Disease
07/24
12/25
NCT04967560: The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD

Recruiting
N/A
64
RoW
deep brain stimulation
Shanghai Mental Health Center, West China Hospital, Huashan Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Brain Hospital, First Affiliated Hospital of Kunming Medical University, Changhai Hospital, SceneRay Corporation, Limited
Obsessive-Compulsive Disorder
07/24
10/24
NCT06542094: Identifying Local Field Potential Biomarkers for Treatment-Resistant Major Depression With Deep Brain Stimulation

Recruiting
N/A
12
RoW
Deep Brain stimulation
West China Hospital, Beijing Pins Medical Co., Ltd
Major Depressive Disorder, Treatment Resistant Depression
07/26
12/26
DBS OCD, NCT06542224: Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation

Recruiting
N/A
16
RoW
Deep Brain stimulation
West China Hospital, Beijing Pins Medical Co., Ltd
Obsessive-Compulsive Disorder
07/26
12/26
NCT06474507: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)

Recruiting
N/A
230
RoW
Calculus bovis sativus (CBS)
Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd.
Ischemic Cerebrovascular Disease, Acute Ischemic Stroke, Cerebral Small Vessel Diseases
07/29
12/29
NCT06474520: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

Recruiting
N/A
250
RoW
Calculus bovis sativus (CBS)
Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd.
Idiopathic Inflammatory Demyelinating Disease, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Acute Disseminated Encephalomyelitis
07/29
12/29
NCT03651986: Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary Nodules

Active, not recruiting
N/A
10560
RoW
ctDNA methylation analysis by NGS
AnchorDx Medical Co., Ltd., Xiangya Hospital of Central South University, West China Hospital, Shanghai Zhongshan Hospital, Shanghai Pulmonary Hospital affiliated to Tongji University, First Hospital of China Medical University, Guizhou Provincial People's Hospital, Shanghai Chest Hospital, First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital Xi'an Jiaotong University, Qilu Hospital of Shandong University, Inner Mongolia People's Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Zhengzhou University, Second Hospital of Jilin University, LanZhou University, Peking University Third Hospital, The First People's Hospital of Yunnan, Shantou Affiliated Hospital of Sun Yat-Sen University, Ruijin Hospital, The Shanghai Jiao Tong University Medical School, Tongji Hospital, The First Affiliated Hospital of Guangzhou Medical University, Xijing Hospital, Air Force Medical University of PLA, Shenzhen People's Hospital, Henan Provincial People's Hospital, Beijing Chao Yang Hospital, Xiamen Second Hospital, The First Affiliated Hospital of Nanchang University
Pulmonary Nodules
09/24
06/25
 

Download Options